1724918

Zolpidem Related Compound A

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): N,N-Dimethyl-2-[7-methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridin-3-yl]-acetamid
• Empirische Formel (Hill-System): C₁₉H₂₁N₃O
• Molekulargewicht: 307.39
• MDL-Nummer: MFCD23136997
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• API-Familie: zolpidem
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• SMILES String: CC1=CC=C(C=C1)C2=C(CC(N(C)C)=O)N3C=CC(C)=CC3=N2
• InChI: 1S/C19H21N3O/c1-13-5-7-15(8-6-13)19-16(12-18(23)21(3)4)22-10-9-14(2)11-17(22)20-19/h5-11H,12H2,1-4H3
• InChIKey: CZVNHSKGTUTQHR-UHFFFAOYSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Zolpidem Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Zolpidem Tartrate
• Zolpidem Tartrate Extended-Release Tablets
• Zolpidem Tartrate Tablets

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

USP issued SDS can be found here.

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS07,GHS09
• Signalwort: Warning
• H-Sätze: H302,H336,H411
• P-Sätze: P261 - P264 - P271 - P273 - P301 + P312 - P304 + P340 + P312
• Gefahreneinstufungen: Acute Tox. 4 Oral - Aquatic Chronic 2 - STOT SE 3
• Zielorgane: Central nervous system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 2
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable